Bain Capital eyes China healthcare, fintech deals

The US private equity fund has amassed $3 billion to spend on Asian deals. Steve Pagliuca tells FinanceAsia which sectors look promising in 2016.

Bain Capital has raised $3 billion for dealmaking in Asia and sees fintech and healthcare in China among the most promising sectors for investment in the coming years.

The Boston-headquartered private equity firm will start putting its fresh capital to work in the region next year, and is looking for transactions where its experience working with similar companies elsewhere gives it an edge. 

“As China transitions to a more service-oriented economy and sectors such as fintech and healthcare become areas for growth they will require capital and expertise and that’s what we bring,” Stephen Pagliuca, arguably Bain Capital's most prominent managing director, told FinanceAsia....

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222